NEW YORK – Austin, Texas-based startup Nuclein has developed a disposable handheld real-time PCR system and a prototype assay for SARS-CoV-2, the virus that causes coronavirus disease COVID-19.
The company is seeking partners to commercialize the system with hopes of making it available for at-home, physician-guided testing, among other potential use spaces.